Peptides ranked by how much human evidence actually backs them (save this):
Strongest data:
- Semaglutide
- Tirzepatide
- Tesamorelin
Promising, thinner data:
- Retatrutide
- GHK-Cu
- BPC-157
Mostly anecdote so far:
- TB-500
- MOTS-c
- Epitalon
Knowing the tier matters more than the hype.
The peptide shortlist if you only care about one goal each:
Fat loss → Retatrutide
Recovery → BPC-157
Skin / aging → GHK-Cu
Focus → Semax
Calm → Selank
Longevity → Epitalon
Visceral fat → Tesamorelin
Bookmark it. You'll come back to this one.
Peptides almost everyone gets backwards:
- BPC-157: doesn't "heal" — it signals where repair goes
- TB-500: not a painkiller — it directs cell migration
- GHK-Cu: not just skincare — shifts thousands of genes younger
-MOTS-c: won't replace training — makes cells burn fuel better
- CJC/Ipamorelin: doesn't add GH — it amplifies your own pulse in deep sleep
Save this before your next protocol.
Peptides almost everyone gets backwards:
- BPC-157: doesn't "heal" — it signals where repair goes
- TB-500: not a painkiller — it directs cell migration
- GHK-Cu: not just skincare — shifts thousands of genes younger
-MOTS-c: won't replace training — makes cells burn fuel better
- CJC/Ipamorelin: doesn't add GH — it amplifies your own pulse in deep sleep
Save this before your next protocol.
Peptides ranked by how much human evidence actually backs them (save this):
Strongest data:
- Semaglutide
- Tirzepatide
- Tesamorelin
Promising, thinner data:
- Retatrutide
- GHK-Cu
- BPC-157
Mostly anecdote so far:
- TB-500
- MOTS-c
- Epitalon
Knowing the tier matters more than the hype.
8/ This is exactly what we're building at PeptideBase:
the FDA's own record on each vendor, recalls, warning letters, verifications, sourced and linked side by side.
Not a rating you trust blindly.
(Launching in 24 hours, follow us for updates)
1/ When a vendor says a drug is "for research only, not for human consumption," that label has a history.
In one case the FDA looked at exactly that label, on this vendor, and rejected it.
Here is what happened when they kept selling anyway.
7/ None of this is our opinion.
It is the FDA's warning letter, the vendor's own live store, and an independent lab.
Before you trust a peptide vendor, check the FDA warning letter database and independent lab grades.
Marketing is not testing.
Calorie counting is quietly becoming the slowest way to lose fat.
Not because it stopped working
because metabolic research now does in months what willpower does in years.
For some the variable was never discipline. It was biology.
Interested in hundreds of dollars of free peptides?
Go to bed on time.
It doses you with natural growth hormone. No injection.
GH great for recovery, muscle synthesis, cellular repair.
Dose is gated to first night’s sleep window.
You miss the dose if you miss the window.
The peptide era is already doing exactly what Bryan's describing quietly.
GLP-1s started as "weight loss drugs."
Now they're cutting heart attacks and strokes in people who never even had diabetes.
Same principle: tools that keep you healthy today are buying you the years to reach whatever lands tomorrow.
Breakthroughs grab the headlines.
Maintenance keeps you alive to read them
For those of you who have a terminal illness, a chronic condition, or debilitating health issue, there is new reason to have hope.
New treatments are arriving that buy more time for the next to arrive. Even for the most vicious of diseases, for example, metastatic pancreatic cancer.
The recent breakthrough, daraxonrasib, nearly doubled overall survival, 6.7 to 13.2 months, with fewer side effects than chemo. It's hard to overstate the significance of this.
In a slow world, a few months doesn't matter much. In a fast world, that could mean the difference to make it to the next life-extending therapy.
We are on a long arc of getting increasingly better at solving disease.
In 1919, Elizabeth Hughes was diagnosed with type 1 diabetes. The only treatment was a starvation diet, which she did for three years. Her weight dropped to 45 pounds at age 14.
Then insulin arrived in 1922. It allowed her to live to 73.
And recently, Sid Sijbrandij used AI and existing biotech infrastructure to fight a recurring osteosarcoma that standard medicine had given up on. Today he has no evidence of disease.
A new era for life is here. It won't appear overnight. Nor will it be all sunshine and rainbows. But we are at the inflection point where hope can dare rise as the sun for those who have been stuck in the darkness.
GHK-Cu does something most $300 serums can't: work at the gene level.
boosts collagen, elastin + glycosaminoglycan synthesis
shown to shift expression of thousands of skin-repair genes
small studies report visible collagen gains in ~12 weeks
Most creams sit on top of the skin. This one signals it.
Tesamorelin is the most ignored peptide that actually has an FDA approval, specifically for reducing deep visceral fat in HIV-associated lipodystrophy.
The approval is narrow, but the mechanism is the interesting part
a GHRH analog: raises your own growth hormone, doesn't replace it
targets visceral fat specifically, not just bodyweight
Narrow label ≠ uninteresting compound.
Topical anti-aging peaked a decade ago.
The next era repairs skin from the inside, at the gene level (research use only):
- GHK-Cu: collagen + elastin synthesis
- Epitalon: telomere + circadian signaling
- Thymosin Beta-4: tissue + barrier repair
Creams sit on top. These rewrite the instructions.